Colin Bier

Mar 27, 2019

Todos Medical appointed Colin Bier to its board of directors. Bier has more than 35 years of clinical expertise, has experience in commercializing diagnostic tests, and has participated in clinical trials, including for Alzheimer's disease.

He previously served as a scientific advisor to and chief development officer of Amarantus Diagnostics.

Todos Medical said that Bier has familiarity with its recent joint venture and the science of LymPro, a diagnostic test for Alzheimer's Disease.